This paper is in the following e-collection/theme issue:

Methods and Feasibility Studies (450)

Published on in Vol 8, No 9 (2019): September

Quality of Life of Patients With Osteosarcoma in the European American Osteosarcoma Study-1 (EURAMOS-1): Development and Implementation of a Questionnaire Substudy

Quality of Life of Patients With Osteosarcoma in the European American Osteosarcoma Study-1 (EURAMOS-1): Development and Implementation of a Questionnaire Substudy

Quality of Life of Patients With Osteosarcoma in the European American Osteosarcoma Study-1 (EURAMOS-1): Development and Implementation of a Questionnaire Substudy

Authors of this article:

Gabriele Calaminus1 Author Orcid Image ;   Meriel Jenney2 Author Orcid Image ;   Lars Hjorth3 Author Orcid Image ;   Katja Baust1 Author Orcid Image ;   Mark Bernstein4 Author Orcid Image ;   Stefan Bielack5 Author Orcid Image ;   Patricia De Vos6 Author Orcid Image ;   Pancras C W Hogendoorn7 Author Orcid Image ;   Gordana Jovic8 Author Orcid Image ;   Mark Krailo9, 10 Author Orcid Image ;   Kiana Kreitz11 Author Orcid Image ;   Neyssa Marina12 Author Orcid Image ;   Babasola O Popoola8 Author Orcid Image ;   Cristina Sauerland11 Author Orcid Image ;   Sigbjørn Smeland13, 14 Author Orcid Image ;   Carmen Teske1 Author Orcid Image ;   Clara V Schweinitz1 Author Orcid Image ;   Jeremy Whelan15 Author Orcid Image ;   Andreas Wiener16 Author Orcid Image ;   Matthew R Sydes8 Author Orcid Image ;   Rajaram Nagarajan17, 18 Author Orcid Image
Article Authors Cited by (6) Tweetations (1) Metrics

Journals

  1. Hecker-Nolting S, Langer T, Blattmann C, Kager L, Bielack S. Current Insights into the Management of Late Chemotherapy Toxicities in Pediatric Osteosarcoma Patients. Cancer Management and Research 2021;Volume 13:8989 View
  2. Bielack S, Kager L, Kühne T, Langer T, Reichardt P, Blattmann C, Kevric M, Mettmann V, Sorg B, Hecker-Nolting S. Establishment, Maintenance, and Performance of the Cooperative Osteosarcoma Study Group (COSS). Cancers 2023;15(5):1520 View
  3. Kondratowski S, Cohen D, Deyell R, Sandhu A, Bush J, Li Z. Immunohistochemical study of histone protein 3 modification in pediatric osteosarcoma identifies reduced H3K27me3 as a marker of poor treatment response. PLOS ONE 2024;19(11):e0309471 View
  4. Sebio A, Berger C, Tabone M, Fernandez N, Tardy F, Grootenhuis M, Palmerini E, Gaspar N, van de Sande M, Haveman L, Gomez R. Quality of Life and Patient‐Reported Outcomes in Patients With Osteosarcoma: A Systematic Review. European Journal of Cancer Care 2025;2025(1) View
  5. Greenzang K, Montgomery K, DuVall A, Roth M, Krailo M, Nuño M, Renfro L, DelRocco N, Doski J, Kelly K, Castellino S, McNeer J, O’Brien M, Reed D, Janeway K, Hinds P, Zupanec S, Parsons S. Incorporation of patient-reported outcomes in pediatric cancer clinical trials: design, implementation, and dissemination. JNCI: Journal of the National Cancer Institute 2025;117(9):1764 View
  6. Parsons S, Montgomery K, Brackett J, Devine K, Embry L, Greenzang K, Lupo P, Nuño M, Rosenberg A, Roth M, Zupanec S, Hinds P. Defining and measuring tolerability in pediatric, adolescent, and young adult oncology: The essential voices. Cancer 2025;131(S2) View